Managers may not have the luxury of patience. Their superiors or board members
may be too remote from the operations to understand or believe reasons
for short-term EP decline, or managers making the investment don't
expect to be around when the project reaches fruition. In such
instances, managers may feel encouraged to make strategic investments
only if the short-term results of those investments are not held against
them.
The short-term impact of a strategic investment can be avoided if the results of that
investment are excluded from operating results by adding back the
project's investment to net assets and adding back any project related
income (or losses) to business unit income.
This treatment may
be the only option for projects with very long lead times before income
is expected to appear, e.g., for delays longer than four or five years.
Beyond that, the time horizon for managers (typically in their positions
for less than five years) make accountability for EP results, or for
any period measure, virtually impossible. The best that
investors can hope for with such lag times is project-based
accountability, that is, holding management to project milestones or
within a budget in the belief that, if the project is completed within
budget, value creation will follow.
While this
treatment leaves management neutral about the short-term results, it
also leaves them without a positive incentive to trade off additional
(or less) investment for additional (or less) income. Thus, exclusion of
results could lead to over-investment, especially if the project began
yielding deficient results versus those originally planned, possibly
encouraging managers to "throw good money after bad" to remedy
the situation. Furthermore,
project income can become impossible to segregate from overall business
unit income as time progresses. Trying to isolate project income may be
like trying to keep track of water from a bucket thrown into a pool.
Even if a project has discrete revenue units, it may have shared
expenses or it may generate collateral revenues for other product lines
that cannot be objectively isolated.